Find Clinical Trials

All CategoriesMedications / Interventions»Cc»Celebrex



Join Paid Clinical Trials



  • Condition:   Thyroid Eye Disease
    Interventions:   Drug: Celecoxib;   Drug: artificial tears
    Sponsor:   Johns Hopkins University
    Recruiting

  • Condition:   Healthy
    Interventions:   Drug: Celecoxib;   Drug: Naproxen;   Drug: Placebo
    Sponsors:   University of Pennsylvania;   National Heart, Lung, and Blood Institute (NHLBI)
    Recruiting

  • Conditions:   Pain, Postoperative;   Urethral Stricture
    Interventions:   Drug: Oxycodone;   Drug: Acetaminophen;   Drug: Gabapentin;   Drug: celebrex;   Drug: Bupivacaine;   Drug: Ibuprofen 800 mg;   Drug: Dexamethasone
    Sponsor:   University of Alabama at Birmingham
    Not yet recruiting

  • Conditions:   Rheumatoid Arthritis;   Cardiovascular Diseases
    Interventions:   Drug: celecoxib 200mg capsule;   Drug: naproxen sodium 550mg tablet;   Drug: Aspirin 81mg tablet
    Sponsor:   Inova Health Care Services
    Recruiting

  • Conditions:   Triple -Negative Breast Cancer;   Estrogen Receptor Negative;   HER2/Neu Negative;   Anatomic Stage IV Breast Cancer AJCC;   Progesterone Receptor Negative
    Interventions:   Procedure: Biopsy;   Procedure: Chemokine Modulation Therapy;   Drug: Celecoxib;   Biological: Recombinant Interferon Alfa-2b;   Drug: Rintatolimod;   Biological: Pembrolizumab
    Sponsor:   Roswell Park Cancer Institute
    Recruiting

  • Conditions:   Type 2 Diabetes;   High Blood Pressure;   Arthritis;   Obesity
    Interventions:   Drug: Metformin;   Drug: Val, Cel and Met XR Low;   Drug: Val, Cel and Met XR High
    Sponsors:   ARKAY Therapeutics;   Albany Medical College
    Not yet recruiting

  • Conditions:   Metastatic Carcinoma in the Liver;   Recurrent Colorectal Carcinoma;   Stage IV Colorectal Cancer AJCC v7;   Stage IVA Colorectal Cancer AJCC v7;   Stage IVB Colorectal Cancer AJCC v7
    Interventions:   Drug: Celecoxib;   Other: Laboratory Biomarker Analysis;   Biological: Recombinant Interferon Alfa-2b;   Drug: Rintatolimod
    Sponsors:   Roswell Park Cancer Institute;   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Pain Management
    Interventions:   Drug: Oxycodone;   Drug: Acetaminophen;   Drug: Gabapentin;   Drug: Celecoxib;   Drug: Hydrocodone-Acetaminophen
    Sponsor:   University of Alabama at Birmingham
    Recruiting

  • Condition:   Osteoarthritis, Hip
    Interventions:   Procedure: Periarticular injection (Deep injection);   Procedure: Periarticular injection (Superficial injection);   Drug: Bupivacaine;   Drug: Placebo
    Sponsor:   Hospital for Special Surgery, New York
    Recruiting

  • Conditions:   Shoulder Pain;   Opioid Use
    Interventions:   Drug: Acetaminophen;   Drug: Celecoxib 200mg;   Drug: Celecoxib 400 mg;   Drug: Ropivacaine;   Drug: Ketorolac;   Drug: Acetaminophen Injectable Product;   Drug: Oxycodone;   Drug: Tramadol;   Drug: Morphine Injectable Solution;   Drug: hydrocodone bitartrate and acetaminophen;   Drug: Morphine;   Drug: Oxycodone Hydrochloride;   Drug: Meloxicam
    Sponsor:   Rush University Medical Center
    Recruiting

  • Condition:   Stiffness Following Total Knee Arthroplasty
    Interventions:   Drug: Dexamethasone;   Drug: Celecoxib
    Sponsors:   Mayo Clinic;   Knee Society
    Recruiting

  • Condition:   Narcotic Use
    Interventions:   Drug: Celecoxib;   Drug: Hydrocodone-Acetaminophen;   Drug: Ketorolac;   Drug: Gabapentin;   Drug: Acetaminophen;   Drug: Diazepam
    Sponsor:   Henry Ford Health System
    Recruiting

  • Conditions:   Meniscus Disorder;   Narcotic Use
    Interventions:   Drug: Celecoxib;   Drug: Hydrocodon/Acetaminophen;   Drug: Ketorolac;   Drug: Gabapentin;   Drug: Acetaminophen;   Drug: Diazepam
    Sponsor:   Henry Ford Health System
    Recruiting

  • Condition:   Anterior Cruciate Ligament Injury
    Interventions:   Drug: Celecoxib;   Drug: Hydrocodone-Acetaminophen;   Drug: Ketorolac;   Drug: Gabapentin;   Drug: Acetaminophen;   Drug: Diazepam
    Sponsor:   Henry Ford Health System
    Recruiting

  • Condition:   Rotator Cuff Tear
    Interventions:   Drug: Celecoxib;   Drug: Ketorolac;   Drug: Gabapentin;   Drug: Acetaminophen;   Drug: Diazepam;   Drug: Hydrocodone-Acetaminophen
    Sponsor:   Henry Ford Health System
    Recruiting

  • Conditions:   Breast Cancer;   Prostate Cancer;   Pancreatic Cancer;   Acute Myelogenous Leukemia
    Interventions:   Procedure: Biopsy;   Drug: ABIRATERONE;   Drug: ENZALUTAMIDE;   Drug: VENETOCLAX;   Drug: PALBOCICLIB;   Drug: All-trans Retinoic Acid;   Drug: BORTEZOMIB;   Drug: CABAZITAXEL;   Drug: OXALIPLATIN;   Drug: FLUOROURACIL;   Drug: FOLINIC ACID;   Drug: CARBOPLATIN;   Drug: PANOBINOSTAT;   Drug: VORINOSTAT;   Drug: PEMBROLIZUMAB;   Drug: BEVACIZUMAB;   Drug: IPILIMUMAB;   Drug: NIVOLUMAB;   Drug: EVEROLIMUS;   Drug: SIROLIMUS;   Drug: CELECOXIB;   Drug: OLAPARIB;   Drug: AFATINIB;   Drug: CABOZANTINIB;   Drug: SORAFENIB;   Drug: DASATINIB;   Drug: ERLOTINIB;   Drug: IDELALISIB;   Drug: IMATINIB;   Drug: LENVATINIB;   Drug: PERTUZUMAB;   Drug: PONATINIB;   Drug: RUXOLITINIB;   Drug: SUNITINIB;   Drug: TRAMETINIB;   Drug: VEMURAFENIB
    Sponsors:   OHSU Knight Cancer Institute;   Oregon Health and Science University;   Prospect Creek Foundation
    Not yet recruiting

  • Conditions:   Osteoarthritis, Knee;   Osteoarthritis, Hip
    Interventions:   Drug: Fasinumab;   Other: Diclofenac;   Other: Celecoxib;   Drug: Matching placebo
    Sponsors:   Regeneron Pharmaceuticals;   Teva Pharmaceutical Industries, Ltd.
    Recruiting

Login to Get Started